. . . . . . . . . "\"Fenofibric acid delayed-release capsules are contraindicated in: patients with severe renal impairment, including those receiving dialysis [see Clinical Pharmacology ( 12.3 patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions ( 5.3 patients with preexisting gallbladder disease [see Warnings and Precautions ( 5.5 nursing mothers [see Use in Specific Populations ( 8.2 patients with hypersensitivity to fenofibric acid or fenofibrate [see Warnings and Precautions ( 5.9 Severe renal dysfunction, including patients receiving dialysis ( 4 , 12.3 ). Active liver disease ( 4 , 5.3 ). Gallbladder disease ( 4 , 5.5 ). Lactation ( 4 , 8.2 ). Known hypersensitivity to fenofibric acid or fenofibrate ( 4 , 5.9 ).\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "PhUqQZ25BRZ6IkqJkZfcJkPeYH4ckOcfwDyfoGkw7marrs2xlsUFnQZaAG0D0BBvWwOS49eyVwJ51e+0DznI7blzvWmWh8D+xCCwcN82VdC83w+LFMx7ch6xi5/MVrBFnIfG270Eg+dlZmxe7bS+5rUBybVJqm1e2CR0Yn+k874=" . . "2021-08-23T12:11:20.014+02:00"^^ . . . . .